Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEARIAS: Tirofiban Enhanced Antiplatelet Therapy in Ruptured Intracranial Aneurysms With Stent
NCT07818083Phase 3Not yet recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Sep 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 3 trial of tirofiban in intracranial aneurysm, subarachnoid hemorrhage (SAH), sponsored by The First Hospital of Fujian Medical University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
intracranial aneurysmsubarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT07818083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07818083.